Investor
SymBiosis
Bentonville · United States
SymBiosis is a biotechnology venture capital firm focused on bioengineering and novel therapeutic platforms for life-threatening diseases.
Stage
Not confirmed
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
About
The firm invests in the future of bioengineering at industrial scale and speed. It partners with companies developing medicines for life-threatening diseases that have well-established approvable endpoints. The firm supports novel therapeutic platforms across any modality using discovery tools for multiple compounds. It targets companies where the lead candidate can achieve human proof-of-concept within the investment horizon. Additionally, supported companies must demonstrate stage-appropriate evidence of repeatable and scalable manufacturing.
How to approach
Submit a non-confidential pitch deck through the contact form on the website.
Portfolio · 4 · tap a company to read about it